{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T17:46:50Z","timestamp":1784656010142,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T00:00:00Z","timestamp":1726185600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126325","type":"journal-article","created":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T23:26:12Z","timestamp":1726183572000},"page":"126325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection"],"prefix":"10.1016","volume":"42","author":[{"given":"Susan D.","family":"Kerfua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Haydon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginette","family":"Wilsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ludi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald P.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose Ademun","family":"Okurut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Atim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses T.","family":"Dhikusooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Kyakuwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126325_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9975(03)00041-0","article-title":"The pathogenesis and diagnosis of foot-and-mouth disease","volume":"129","author":"Alexandersen","year":"2003","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2024.126325_bb0010","series-title":"Transboundary animal diseases: Assessment of socio-economic impacts and institutional responses","first-page":"119","author":"Otte","year":"2004"},{"key":"10.1016\/j.vaccine.2024.126325_bb0015","author":"Rushton"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126325_bb0020","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1297-9716-44-116","article-title":"Foot-and-mouth disease: past, present and future","volume":"44","author":"Jamal","year":"2013","journal-title":"Vet Res"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126325_bb0025","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/tbed.12373","article-title":"Review of the global distribution of foot-and-mouth disease virus from 2007 to 2014","volume":"64","author":"Brito","year":"2017","journal-title":"Transbound Emerg Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126325_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.20506\/rst.30.1.2022","article-title":"Combining livestock trade patterns with phylogenetics to help understand the spread of foot-and-mouth disease in sub-Saharan Africa, the Middle East and Southeast Asia","volume":"30","author":"Di Nardo","year":"2011","journal-title":"Rev Sci Tech Off Int Epizoo"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126325_bb0035","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41559-018-0636-x","article-title":"Waves of endemic foot-and-mouth disease in eastern Africa suggest feasibility of proactive vaccination approaches","volume":"2","author":"Casey-Bryars","year":"2018","journal-title":"Nat Ecol Evol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126325_bb0040","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00705-010-0742-9","article-title":"Co-circulation of two extremely divergent serotype SAT 2 lineages in Kenya highlights challenges to foot-and-mouth disease control","volume":"155","author":"Sangula","year":"2010","journal-title":"Arch Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126325_bb0045","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3201\/eid2101.140995","article-title":"Foot-and-mouth disease virus serotype SAT 3 in long-horned Ankole calf, Uganda","volume":"21","author":"Dhikusooka","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126325_bb0050","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1111\/tbed.12200","article-title":"Molecular characterization of foot-and-mouth disease viruses collected in Tanzania between 1967 and 2009","volume":"62","author":"Kasanga","year":"2015","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2024.126325_bb0055","first-page":"119","article-title":"Occurrence of foot-and-mouth disease virus serotypes in Uganda and Tanzania (2003 to 2015): a review and implications for prospective regional disease control","volume":"12","author":"Kerfua","year":"2020","journal-title":"Can J Agric"},{"key":"10.1016\/j.vaccine.2024.126325_bb0060","series-title":"Principles, Stage description and Standards","article-title":"The Progressive Control Pathway for FMD control (PCP-FMD)","author":"FAO\/OIE","year":"2011"},{"issue":"16","key":"10.1016\/j.vaccine.2024.126325_bb0065","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1016\/j.vaccine.2014.01.071","article-title":"Retrospective evaluation of foot-and-mouth disease vaccine effectiveness in Turkey","volume":"32","author":"Knight-Jones","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126325_bb0070","author":"The Global Foot-and-Mouth disease Control"},{"key":"10.1016\/j.vaccine.2024.126325_bb0075","series-title":"Foot and mouth disease vaccination and post-vaccination monitoring","author":"Ferrari","year":"2016"},{"key":"10.1016\/j.vaccine.2024.126325_bb0080","series-title":"Manual Of Diagnostic Tests And Vaccines For Terrestrial Animal","author":"World Organisation for Animal Health","year":"2010"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126325_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0378-1135(02)00046-9","article-title":"Early antibody responses of cattle for foot-and-mouth disease quadrivalent double oil emulsion vaccine","volume":"87","author":"Patil","year":"2002","journal-title":"Vet Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126325_bb0090","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.3390\/v13091830","article-title":"Targeted FMD vaccines for eastern Africa: the AgResults foot and mouth disease vaccine challenge project","volume":"13","author":"Hammond","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.126325_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2022.1027006","article-title":"Predicting cross-protection against foot-and-mouth disease virus strains by serology after vaccination","volume":"9","author":"Gubbins","year":"2022","journal-title":"Front Vet Sci"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126325_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1017\/S0950268800052699","article-title":"Failure of vaccination to prevent outbreaks of foot-and-mouth disease","volume":"116","author":"Woolhouse","year":"1996","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2024.126325_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.06.033","article-title":"An IgG1 single-dilution avidity ELISA predicts cross-protection against heterologous foot-and-mouth disease virus challenge after vaccination","author":"Cardoso","year":"2024","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126325_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044365","article-title":"Interferon-\u03b3 induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection","volume":"7","author":"Oh","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126325_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0022-1759(86)90442-4","article-title":"A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. II Application","volume":"93","author":"Hamblin","year":"1986","journal-title":"J Immunol Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126325_bb0120","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0166-0934(02)00196-9","article-title":"A solid-phase blocking ELISA for detection of type O foot-and-mouth disease virus antibodies suitable for mass serology","volume":"107","author":"Ch\u00e9nard","year":"2003","journal-title":"J Virol Methods"},{"issue":"37","key":"10.1016\/j.vaccine.2024.126325_bb0125","doi-asserted-by":"crossref","first-page":"5515","DOI":"10.1016\/j.vaccine.2019.07.102","article-title":"Estimating the protection afforded by foot-and-mouth disease vaccines in the laboratory","volume":"37","author":"Paton","year":"2019","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126325_bb0130","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11121818","article-title":"The immunogenicity of a foot-and-mouth disease virus serotype O vaccine in commercial and subsistence cattle herds in Zambia","volume":"11","author":"Banda","year":"2023","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2024.126325_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fvets.2016.00102","article-title":"Challenges of generating and maintaining protective vaccine-induced immune responses for foot-and-mouth disease virus in pigs","volume":"3","author":"Lyons","year":"2016","journal-title":"Front Vet Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126325_bb0140","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01320790","article-title":"Thermal stability of foot-and-mouth disease virus","volume":"70","author":"Doel","year":"1981","journal-title":"Arch Virol"},{"issue":"35","key":"10.1016\/j.vaccine.2024.126325_bb0145","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1016\/j.vaccine.2021.07.001","article-title":"The selection of naturally stable candidate foot-and-mouth disease virus vaccine strains for East Africa","volume":"39","author":"Jackson","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.126325_bb0150","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4102\/ojvr.v75i1.84","article-title":"Evaluation of different adjuvants for foot-and-mouth disease vaccine containing all the SAT serotypes","volume":"75","author":"Cloete","year":"2008","journal-title":"Onderstepoort J Vet Res"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126325_bb0155","doi-asserted-by":"crossref","first-page":"913","DOI":"10.20506\/rst.15.3.954","article-title":"The performance of southern African territories serotypes of foot and mouth disease antigen in oil-adjuvanted vaccines","volume":"15","author":"Hunter","year":"1996","journal-title":"Rev Sci Tech"},{"issue":"1623","key":"10.1016\/j.vaccine.2024.126325_bb0160","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2012.0381","article-title":"Elimination of foot-and-mouth disease in South America: lessons and challenges","volume":"368","author":"Naranjo","year":"2013","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126325_bb0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","article-title":"FMD vaccines","volume":"91","author":"Doel","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2024.126325_bb0170","series-title":"Infectious diseases of livestock","article-title":"Foot and mouth disease","author":"Thomson","year":"2004"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126325_bb0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11250-012-0254-6","article-title":"Effectiveness of vaccines and vaccination programs for the control of foot-and-mouth disease in Uganda, 2001-2010","volume":"45","author":"Muleme","year":"2013","journal-title":"Trop Anim Health Prod"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2024.126480","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:41:57Z","timestamp":1741887717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24010077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24010077"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126325","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.vaccine.2024.126480","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of commercial quadrivalent foot-and-mouth disease vaccines against east African virus strains reveals limited immunogenicity and duration of protection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126325","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126325"}}